• Earnings Flash (MESO) Mesoblast Limited Reports Q4 Revenue $36.0M, vs. FactSet Est of $36.9M marketscreener.com Fri, 10 Jul 2026 08:26:51 GMT
• Mesoblast's Fiscal Fourth Quarter Net Revenue from MSC Therapy Product Sales Beats Jefferies Forecast marketscreener.com Fri, 10 Jul 2026 06:38:17 GMT
• Ryoncil revenue hits US$36M in Q4, FY26 total at US$115M scanx.trade Fri, 10 Jul 2026 03:29:32 GMT
• Mesoblast Reports Strong RYONCIL® Revenue, Exceeding Projections Sharecafe Fri, 10 Jul 2026 00:39:43 GMT
• Ryoncil® Delivers Net Revenue of US$36M for the Fourth Quarter Ended 30 June 2026 The Manila Times Fri, 10 Jul 2026 00:35:26 GMT
• Mesoblast shares: Q4 earnings top projections The Motley Fool Australia Fri, 10 Jul 2026 00:31:22 GMT
• Why Mesoblast (ASX: MSB) Continues to Advance Cell-Based Therapies Kalkine Thu, 09 Jul 2026 23:54:00 GMT
• Mesoblast (ASX:MSB): What's Behind the Renewed Interest in This Cell Therapy Company Kalkine Thu, 09 Jul 2026 02:32:00 GMT
• Mesoblast Ltd outlook for regenerative medicine. MESO stock aligns long-term strategy AD HOC NEWS Tue, 07 Jul 2026 18:49:35 GMT
• Mesoblast (ASX:MSB): The Stem Cell Therapy Company on the Cusp of Commercial Reality Kalkine Mon, 06 Jul 2026 06:59:00 GMT
• Why Mesoblast (ASX:MSB) Is Up 9.3% After FDA Accepts Modular BLA Review For Rexlemestrocel-L simplywall.st Fri, 03 Jul 2026 16:44:52 GMT
• mesoblast (asx:msb): why is asx 200 watching its cell therapy milestone? Kalkine Media Fri, 03 Jul 2026 05:45:00 GMT
• Chronic Lower Back Pain Pipeline 2026: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Collegium Pharma,... Barchart.com Fri, 03 Jul 2026 00:30:20 GMT
• Is Mesoblast (ASX:MSB) Undervalued Following FDA Progress For Rexlemestrocel L? simplywall.st Thu, 02 Jul 2026 05:50:10 GMT
• Bell Potter Maintains MESOBLAST LTD(MEOBF.US) With Buy Rating, Raises Target Price to $3.08 Moomoo Thu, 02 Jul 2026 01:31:00 GMT
• Mesoblast (NASDAQ: MESO) moves rexlemestrocel-L BLA into FDA modular review Stock Titan Wed, 01 Jul 2026 07:00:00 GMT
• Mesoblast Seeks FDA Approval for Rexlemestrocel-L in LVAD Patients The Clinical Trial Vanguard Wed, 01 Jul 2026 06:53:23 GMT
• Mesoblast (MESO) Secures FDA Filing for Rexlemestrocel-L Review GuruFocus Wed, 01 Jul 2026 02:05:37 GMT
• mesoblast receives biologics license application filing number from us fda; shares up 3% marketscreener.com Wed, 01 Jul 2026 02:02:16 GMT
• duratec (asx:dur), elsight (asx:els) and mesoblast (asx:msb): why these growth stocks are drawing market attention Kalkine Media Wed, 01 Jul 2026 01:14:00 GMT
• mesoblast gets fda bla filing number for rexlemestrocel-l to treat end-stage heart failure with lvads Pluang Wed, 01 Jul 2026 01:05:09 GMT
• mesoblast seeks faster fda review for heart failure cell therapy Stock Titan Wed, 01 Jul 2026 00:41:06 GMT
• mesoblast receives bla filing number and requests modular review for rexlemestrocel-l in patients with end-stage heart failure and... Yahoo Finance Singapore Wed, 01 Jul 2026 00:38:00 GMT
• Mesoblast Receives BLA Filing Number and Requests Modular Review for Rexlemestrocel-L in Patients with End-Stage Heart Failure and... Yahoo Finance Singapore Tue, 30 Jun 2026 07:00:00 GMT
• Mesoblast seeks faster FDA review for heart failure cell therapy Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• mesoblast (nasdaq: meso) moves rexlemestrocel-l bla into fda modular review Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• flight centre (asx:flt), macquarie technology (asx:maq) and mesoblast (asx:msb): founder-led companies drawing market attention Kalkine Media Tue, 30 Jun 2026 01:11:00 GMT
• mesoblast (asx:msb) climbs as biotech bulls return to the asx healthcare trade Kalkine Mon, 29 Jun 2026 13:58:00 GMT
• enterprise value to ebit forward of mesoblast limited – nasdaq:meso TradingView Sat, 27 Jun 2026 10:30:50 GMT
• enterprise value to ebitda forward of mesoblast limited – ham:lwb TradingView Sat, 27 Jun 2026 07:06:34 GMT
• price to earnings forward of mesoblast limited – asx:msb TradingView Sat, 27 Jun 2026 06:47:34 GMT
• mesoblast limited sponsored adr actuals & estimates (ls:a4004r) TradingView Sat, 27 Jun 2026 06:04:16 GMT
• mesoblast limited sponsored adr actuals & estimates (gettex:lwb1) TradingView Fri, 26 Jun 2026 17:00:44 GMT
• fda approved, europe unconvinced: omeros' stem cell transplant treatment hits regulatory divide Benzinga Fri, 26 Jun 2026 15:16:26 GMT
• mesoblast ltd consensus and trial focus, shares watched on nasdaq AD HOC NEWS Fri, 26 Jun 2026 12:12:41 GMT
• Mesoblast (ASX:MSB) Slips 5% — Biotech Bulls Forced to Recheck Chart Kalkine Fri, 26 Jun 2026 07:00:00 GMT
• mesoblast limited draws usd 50 million from five-year non-dilutive facility marketscreener.com Thu, 25 Jun 2026 11:51:10 GMT
• mesoblast draws $50m from five-year facility to retire existing debt StreetInsider Thu, 25 Jun 2026 07:26:40 GMT
• Mesoblast (NASDAQ: MESO) draws US$50M, refinances high-cost debt Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• Mesoblast Accesses $50 Million Credit Line to Refinance Debt Obligations marketscreener.com Thu, 25 Jun 2026 07:00:00 GMT
• mesoblast draws us$50 million from five-year non-dilutive facility The Manila Times Thu, 25 Jun 2026 07:00:00 GMT
• mesoblast secures $50m from a new 5-year loan to retire costly short-term debt and fund growth. Pluang Thu, 25 Jun 2026 03:26:57 GMT
• mesoblast (asx:msb) strengthens funding position through new five-year credit facility Kalkine Thu, 25 Jun 2026 03:00:00 GMT
• mesoblast draws us$50 million from non-dilutive facility Finance News Network Thu, 25 Jun 2026 01:29:52 GMT
• mesoblast draws $50 million from facility provided by shareholder Moomoo Thu, 25 Jun 2026 01:02:39 GMT
• mesoblast ltd (meso) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 24 Jun 2026 08:03:38 GMT
• mesoblast ltd (meso) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 24 Jun 2026 07:38:22 GMT
• Mesoblast Draws US$50 Million from Five-Year Non-Dilutive Facility Yahoo Finance Wed, 24 Jun 2026 07:00:00 GMT
• Mesoblast Draws $50 Million From Facility Provided by Shareholder Moomoo Wed, 24 Jun 2026 07:00:00 GMT
• mesoblast ltd (meso) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• mesoblast ltd (meso) financial health: profitability & balance sheet analysis TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• msb (asx:msb): the revenue milestone keeping this biotech on investor watchlists Kalkine Media Tue, 23 Jun 2026 06:30:00 GMT
• mesoblast (asx:msb) why this biotech refuses to leave spotlight Kalkine Mon, 22 Jun 2026 07:28:00 GMT
• mesoblast ltd (meso) financial health: profitability & balance sheet analysis TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• mesoblast (asx:msb) asx 300 faces a bigger commercial test Kalkine Media Sun, 21 Jun 2026 04:25:00 GMT
• Mesoblast (ASX:MSB) Is Up 9.2% After Ryoncil’s Near-US$100m Debut And Revascor FDA Progress – Has The Bull Case Changed? simplywall.st Sat, 20 Jun 2026 16:35:32 GMT
• mesoblast (asx:msb): biotech heavyweight keeps investors guessing ahead of key fda moments Kalkine Fri, 19 Jun 2026 07:00:00 GMT
• what is driving increased trading activity in mesoblast (asx:msb) stock? Kalkine Fri, 19 Jun 2026 07:00:00 GMT
• mesoblast q1 2026 earnings: narrower-than-expected loss misses estimates, stock edges higher on pipeline progress - eps surprise h... dars.gov.et Fri, 19 Jun 2026 07:00:00 GMT
• mesoblast and 4dmedical: the biotech trend quietly reshaping the market Kalkine Media Fri, 19 Jun 2026 06:46:00 GMT
• mesoblast ltd (meso) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 20:24:07 GMT
• mesoblast ltd (meso) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 18:37:17 GMT
• mesoblast ltd (meso) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 18:36:19 GMT
• mesoblast ltd (meso) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 18:08:58 GMT
• mesoblast ltd (meso) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 18:08:47 GMT
• why is this asx biotech stock blasting higher today? The Motley Fool Australia Thu, 18 Jun 2026 07:00:00 GMT
• mesoblast (asx:msb) leads asx gainers following high-volume trading session Kalkine Thu, 18 Jun 2026 02:49:00 GMT
• mesoblast ltd (meso) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Thu, 18 Jun 2026 00:56:48 GMT
• mesoblast ltd (meso) dividends & stock splits: historical payouts and event timeline TradingKey Thu, 18 Jun 2026 00:23:48 GMT
• mesoblast ltd (meso) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 07:00:00 GMT
• mesoblast ltd (meso) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 07:00:00 GMT
• mesoblast ltd (meso) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 07:00:00 GMT
• mesoblast ltd (meso) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 07:00:00 GMT
• stem-cell momentum builds: are these asx biotech leaders ready? Kalkine Media Fri, 12 Jun 2026 05:14:00 GMT
• mesoblast says jpmorgan ceases to be substantial holder marketscreener.com Fri, 12 Jun 2026 03:39:16 GMT
• prenzler’s three asx stem-cell stocks to watch as sector matures Stockhead Thu, 11 Jun 2026 20:30:05 GMT
• kina securities and 2 other stocks that may be trading below their estimated value on the asx simplywall.st Thu, 11 Jun 2026 07:00:00 GMT
• mesoblast (nasdaq: meso) leverages ryoncil cash flow to fund major phase 3 cell therapy programs Stock Titan Wed, 10 Jun 2026 12:50:58 GMT
• [6-k] mesoblast ltd current report (foreign issuer) | meso sec filing - form 6-k Stock Titan Wed, 10 Jun 2026 12:50:58 GMT
• buy, hold, sell: mesoblast, mineral resources, and woolworths shares MSN Tue, 09 Jun 2026 21:01:41 GMT
• buy, hold, sell: mesoblast, mineral resources, and woolworths shares MSN Sun, 07 Jun 2026 11:52:55 GMT
• meso financials: revenue breakdown, margins & competitor comparison Intellectia AI Sat, 06 Jun 2026 16:59:51 GMT
• mesoblast climbs (asx:msb) as biotech buyers return to the health sector Kalkine Fri, 05 Jun 2026 07:00:00 GMT
• mesoblast climbs (asx:msb) as biotech buyers return to the health sector Kalkine Thu, 04 Jun 2026 14:05:00 GMT
• Mesoblast Limited (MESO) Presents at ASX CEO Connect June 2026 - Slideshow (NASDAQ:MESO) 2026-06-04 Seeking Alpha Thu, 04 Jun 2026 07:00:00 GMT
• mesoblast ltd stock (au000000msb8): nasdaq-listed biotech in focus after recent price swings AD HOC NEWS Wed, 03 Jun 2026 04:31:16 GMT
• buy, hold, sell: mesoblast, mineral resources, and woolworths shares MSN Fri, 29 May 2026 08:06:01 GMT
• mesoblast ltd stock (au000000msb8): asx biotech in focus after recent news flow and share-price swin AD HOC NEWS Thu, 28 May 2026 15:03:11 GMT
• Does Mesoblast (ASX:MSB) Deserve a Spot on Your Healthcare Watchlist? Kalkine Mon, 25 May 2026 07:00:00 GMT
• mesoblast ltd stock (au000000msb8): cell therapy hopes meet regulatory reality AD HOC NEWS Thu, 21 May 2026 21:42:13 GMT
• mach natural resources, mesoblast and other big stocks moving lower in tuesday's pre-market session MSN Thu, 21 May 2026 17:09:21 GMT
• a big milestone for this asx biotech. here's why the share price is moving MSN Thu, 21 May 2026 10:36:06 GMT
• why amaero, mesoblast, telix, and tivan shares are charging higher today MSN Tue, 19 May 2026 03:13:52 GMT
• mesoblast ltd stock (au000000msb8): focus turns to fda path and cash runway after latest regulatory AD HOC NEWS Sun, 17 May 2026 07:00:00 GMT
• mesoblast ltd stock (au000000msb8): shares gain 2% amid clinical momentum AD HOC NEWS Thu, 14 May 2026 07:00:00 GMT
• asx stocks trading at an estimated discount of up to 45.8% below intrinsic value simplywall.st Wed, 13 May 2026 19:24:21 GMT
• half year 2026 mesoblast ltd earnings presentation transcript GuruFocus Tue, 12 May 2026 11:25:17 GMT
• half year 2025 mesoblast ltd earnings presentation transcript GuruFocus Tue, 12 May 2026 11:14:19 GMT
• a big milestone for this asx biotech. here's why the share price is moving MSN Tue, 12 May 2026 11:07:18 GMT
• why mesoblast could be the asx biotech stock back in focus Kalkine Media Tue, 12 May 2026 01:10:00 GMT
• why mesoblast is back in focus among asx biotech stocks Kalkine Media Tue, 12 May 2026 00:02:00 GMT
• buy, hold, sell: mesoblast, mineral resources, and woolworths shares MSN Sun, 10 May 2026 11:53:06 GMT
• mach natural resources, mesoblast and other big stocks moving lower in tuesday's pre-market session MSN Fri, 08 May 2026 15:31:30 GMT
• mesoblast shares in focus after key phase 3 milestone for low back pain MSN Fri, 08 May 2026 04:18:45 GMT
• buy, hold, sell: mesoblast, mineral resources, and woolworths shares MSN Thu, 07 May 2026 19:01:56 GMT
• mach natural resources, mesoblast and other big stocks moving lower in tuesday's pre-market session MSN Thu, 07 May 2026 15:26:35 GMT
• assessing mesoblast (asx:msb) valuation after phase 3 recruitment milestone for rexlemestrocel l simplywall.st Thu, 07 May 2026 07:00:00 GMT
• fresh commercial activity surrounds mesoblast during asx 200 trading session Kalkine Media Thu, 07 May 2026 06:03:00 GMT
• mesoblast advances clinical path as market reassesses outlook Kalkine Media Thu, 07 May 2026 04:08:00 GMT
Mesoblast Limited(NASDAQ:MESO) 
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine...
Website: http://www.mesoblast.com
Founded: 2004
Full Time Employees: 102
CEO: Silviu Itescu
Sector: Healthcare
Industry: Biotechnology